Close
Help
Need Help?



Drug Target Insights Added to Gale InfoTrac Custom Journals

Posted Mon, Sep, 24,2012

Libertas is pleased to announce that Drug Target Insights has now been added to Gale's InfoTrac Custom Journals database.

GALE operates more than 600 databases, including the popular InfoTrac and General Reference series. The Michigan based company is popular with authors working in the USA, so inclusion of Drug Target Insights in GALE's InfoTrac Custom Journals will increase article visibility in North America.

In addition to it's American popularity, GALE has offices in Europe, the Middle East, Africa, Asia, Australia, New Zealand and Latin America. Libertas' partnership with GALE will provide a further strengthening of the already substantial visibility achieved by Drug Target Insights, and make articles published in the journal accessible to an even larger audience around the world.

To see where else the journal is indexed, visit the Drug Target Insights homepage

share on

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
This is the first time we published an article in Substance Abuse: Research and Treatment, and we were pleased to find that the publishing staff were extremely helpful in guiding our submission through all the hoops. More important they answered our concerns without delay and where necessary made changes in the page proofs in accord with our wishes. I have published upwards of 80 or 90 articles, chapters and edited volumes, and I have never worked ...
Dr Jan Howard (Senior Scientific Advisor, Westat Corporation, Rockville, Maryland)
More Testimonials

Quick Links

Follow Us We make it easy to find new research papers.
Email AlertsRSS Feeds
FacebookGoogle+Twitter
PinterestTumblrYouTube

SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results